The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?
Saved in:
| Title: | The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research? |
|---|---|
| Authors: | Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA., Charalambous S; The Aurum Institute, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Churchyard G; The Aurum Institute, Johannesburg, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Cobelens F; Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Fernández-Escobar C; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain., Frick M; Tuberculosis Project, Treatment Action Group, New York, NY, USA., Hanekom W; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Hatherill M; Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Hill PC; Center for International Health, University of Otago, Dunedin, New Zealand., Pandey S; BL Pandey Foundation for Social Initiatives, Delhi, India., Rangaka MX; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Lemos EF; Prison Community Advisory Board, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; State University of Mato Grosso do Sul, Campo Grande, Brazil., da Silva AM; Prison Community Advisory Board, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil., Croda J; Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; Yale University School of Public Health, New Haven, CT, USA. Electronic address: julio.croda@fiocruz.br., Garcia-Basteiro AL; Centro de Investigação em Saúde de Manhiça, Manhiça, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain; Department of Preventive Medicine and Epidemiology, Hospital Clínic Barcelona, Barcelona, Spain. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Dec; Vol. 25 (12), pp. e722-e729. Date of Electronic Publication: 2025 Jun 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
